Activists object to Naresh Trehan on panel reviewing pharma marketing

The Working Group on Access to Medicines and Treatments has urged the Department of Pharmaceuticals to replace Medanta chairman Dr Naresh Trehan on a Supreme Court-directed committee examining pharmaceutical marketing rules. Citing a potential conflict of interest, the group said the panel, which will review the voluntary UCPMP 2024 code, must remain independent and impartial.